Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc.

ALLO
Allogene Therapeutics, Inc.US flagNASDAQ Global Select
2.12
USD
-0.03
- -
517.00MMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
114
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
114
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
-114
- -
- -
- -
- -
- Operating Expenses
- -
193
202
258
294
336
315
258
207
+ Selling, General & Admin
- -
41
57
65
74
79
72
65
57
+ Research & Development
- -
152
145
193
220
256
243
192
150
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-193
-202
-258
-180
-336
-314
-257
-207
- Non-Operating (Income) Loss
- -
19
-17
58
2
5
13
- -
-16
+ Interest Expense, Net
- -
-2
-17
-9
-2
-5
-18
-20
-18
+ Interest Expense
- -
3
- -
- -
- -
- -
- -
- -
1
- Interest Income
- -
6
17
9
2
5
18
20
19
+ Other Non-Op (Income) Loss
- -
21
- -
67
4
9
31
20
2
Pretax Income
- -
-212
-185
-316
-182
-340
-327
-257
-191
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-212
-185
-316
-182
-340
-327
-258
-191
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-212
-185
-316
-182
-340
-327
-258
-191
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-212
-185
-316
-182
-340
-327
-258
-191
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-212
-185
-316
-182
-340
-327
-258
-191
EBIT
- -
-193
-202
-258
-180
-336
-314
-257
-207
EBITDA
- -
-191
-197
-251
-170
-321
-300
-244
-195
EBITDA Margin (%)
- -
- -
- -
- -
-148.78
-205,923.72
-316,097.89
-1,108,377.27
- -
EBITA
- -
-193
-202
-258
-180
-336
-314
-257
-207
Gross Margin (%)
- -
- -
- -
- -
100
100
100
100
- -
Operating Margin (%)
- -
- -
- -
- -
-157.94
-215,087.18
-331,044.21
-1,170,372.73
- -
Profit Margin (%)
- -
- -
- -
- -
-159.57
-218,214.1
-344,489.47
-1,170,863.64
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
2
5
8
10
14
14
14
12
Basic Weighted Avg Shares
- -
29
101
120
136
143
157
195
221
Basic EPS, GAAP
- -
-7.31
-1.83
-2.63
-1.34
-2.38
-2.09
-1.32
-0.87
Basic EPS from Cont Ops
- -
-7.31
-1.83
-2.63
-1.34
-2.38
-2.09
-1.32
-0.87
Diluted Weighted Avg Shares
- -
29
101
120
136
143
157
195
221
Diluted EPS, GAAP
- -
-7.31
-1.83
-2.63
-1.34
-2.38
-2.09
-1.32
-0.87
Diluted EPS from Cont Ops
- -
-7.31
-1.83
-2.63
-1.34
-2.38
-2.09
-1.32
-0.87

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
468
545
845
471
529
459
303
258
+ Cash, Cash Equivalents & STI
- -
459
531
828
457
517
449
292
250
+ Cash & Cash Equivalents
- -
92
175
183
173
62
83
75
52
+ ST Investments
- -
367
355
645
284
455
366
217
199
+ Accounts & Notes Receiv
- -
3
2
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
3
2
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
5
12
17
14
12
10
11
8
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
306
173
383
580
293
184
245
158
+ Property, Plant & Equip, Net
- -
42
101
160
181
196
163
131
113
+ Property, Plant & Equip
- -
43
106
173
204
233
214
194
185
- Accumulated Depreciation
- -
1
5
13
23
37
51
63
73
+ LT Investments & Receivables
- -
262
63
208
382
76
4
81
8
+ LT Investments
- -
262
63
208
382
76
4
81
8
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
2
9
15
16
20
17
33
37
+ Total Intangible Assets
- -
1
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
1
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
2
9
15
16
20
17
33
37
Total Assets
- -
774
718
1,228
1,051
822
643
549
416
+ Payables & Accruals
- -
21
19
39
28
30
18
16
14
+ Accounts Payable
- -
12
9
10
10
14
6
5
4
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
8
10
29
18
16
12
10
10
+ ST Debt
- -
- -
2
3
3
6
7
8
8
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
2
3
3
6
7
8
8
+ Other ST Liabilities
- -
9
12
52
16
18
13
12
10
+ Deferred Revenue
- -
- -
- -
39
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
9
12
13
16
18
13
12
10
Total Current Liabilities
- -
29
33
94
48
54
37
36
33
+ LT Debt
- -
34
51
51
70
95
88
83
75
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
34
51
51
70
95
88
83
75
+ Other LT Liabilities
- -
7
4
3
8
6
5
8
16
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
7
4
3
8
6
5
8
16
Total Noncurrent Liabilities
- -
41
56
54
78
101
94
91
91
Total Liabilities
- -
71
89
148
126
155
131
127
123
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
914
1,024
1,726
1,822
1,912
2,075
2,242
2,303
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
914
1,024
1,726
1,822
1,912
2,075
2,242
2,303
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
-212
-396
-646
-895
-1,235
-1,562
-1,820
-2,011
+ Other Equity
- -
- -
1
- -
-3
-10
-1
- -
- -
Equity Before Minority Interest
- -
703
629
1,080
925
667
512
422
293
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
703
629
1,080
925
667
512
422
293
Total Liabilities & Equity
- -
774
718
1,228
1,051
822
643
549
416
Shares Outstanding
114
121
124
140
143
144
169
212
229
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
34
53
54
73
101
95
91
83
Net Debt
- -
-92
-175
-183
-173
-62
-83
-75
-52
Net Debt to Equity
- -
-13.15
-27.84
-16.98
-18.73
-9.28
-16.23
-17.82
-17.67
Tangible Common Equity Ratio
- -
90.86
87.63
87.93
88.04
81.17
79.68
76.94
70.34
Current Ratio
- -
15.89
16.46
8.96
9.84
9.84
12.38
8.54
7.93
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
- -
-212
-185
-316
-182
-340
-327
-258
-191
+ Depreciation & Amortization
- -
2
5
8
10
14
14
14
12
+ Non-Cash Items
- -
153
49
140
19
102
97
68
40
+ Stock-Based Compensation
- -
19
46
65
81
84
66
52
38
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
20
18
2
+ Other Non-Cash Adj
- -
135
3
75
-62
18
10
-1
- -
+ Chg in Non-Cash Work Cap
- -
12
-7
54
-32
4
-21
-25
-11
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-9
-5
-3
3
3
1
- -
3
+ Inc (Dec) in Accts Payable
- -
21
5
19
3
7
-14
-2
-4
+ Inc (Dec) in Other
- -
- -
-7
38
-38
-5
-8
-23
-10
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-45
-137
-115
-185
-221
-238
-200
-149
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-3
-51
-66
-21
-5
-2
-1
- -
+ Acq of Fixed Prod Assets
- -
-3
-51
-66
-21
-5
-2
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
344
54
622
- -
- -
91
112
22
+ Increase in Capital Stock
- -
344
54
622
- -
- -
91
112
22
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-627
220
-439
203
111
165
76
96
+ Dec in LT Investment
- -
22
473
598
728
359
603
438
234
+ Inc in LT Investment
- -
-649
-253
-1,038
-526
-248
-439
-361
-138
+ Net Cash From Acq & Div
- -
- -
-5
- -
-18
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
-5
- -
-18
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
-2
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-633
164
-505
164
106
163
76
96
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
117
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
117
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
311
5
12
12
3
5
5
8
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
771
59
634
12
3
96
117
30
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
94
86
13
-9
-111
21
-8
-24
EBITDA
- -
-191
-197
-251
-170
-321
-300
-244
-195
EBITDA Margin (%)
- -
- -
- -
- -
-148.78
-205,923.72
-316,097.89
-1,108,377.27
- -
Free Cash Flow
- -
-48
-188
-181
-206
-226
-239
-201
-150
Net Cash Paid for Acquisitions
- -
- -
5
- -
18
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
69
-188
-181
-206
-226
-239
-201
-150
Free Cash Flow per Basic Share
- -
-1.65
-1.86
-1.5
-1.52
-1.58
-1.52
-1.03
-0.68
Price/Free Cash Flow
- -
-18.82
-30.33
-61.83
-12.4
-4.18
-2.13
-2.08
-2.03
Cash Flow to Net Income
- -
0.21
0.74
0.36
1.02
0.65
0.73
0.78
0.78
Capital Expenditures
- -
-3
-51
-66
-21
-5
-2
-1
- -